In the high-stakes world of medical technology, where visibility often equals valuation, medrad.com operates as a ghost—a $64 million revenue entity with virtually zero public digital footprint. This isn't a glitch; it's a strategic play by Bayer.

"The most successful B2B medical platforms don't chase traffic—they own the conversation behind closed doors."

The contact emails ([email protected]) reveal the true intent: this is a compliance and information channel, not a lead-generation engine. For founders and investors, this is a masterclass in B2B restraint—building a specialized tool for a specialized audience without diluting its value through public analytics.

• Zero public traffic suggests a fully authenticated, gated experience
• Revenue of $64M from 255 employees implies high-value per-head productivity
• Tech stack (Tailwind, Bootstrap, PWA) prioritizes speed and reliability over flashy UX
• Leadership includes CFO and compliance executives, not just marketing